Stockholders' Equity Attributable to Parent in GBP of TC BioPharm (Holdings) plc from Q4 2021 to Q4 2024

Taxonomy & unit
us-gaap: USD and GBP
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
TC BioPharm (Holdings) plc quarterly Stockholders' Equity Attributable to Parent history and change rate from Q4 2021 to Q4 2024.
  • TC BioPharm (Holdings) plc Stockholders' Equity Attributable to Parent for the quarter ending 31 Dec 2024 was £3.01M, a 12.1% increase year-over-year.
Stockholders' Equity Attributable to Parent, Quarterly (GBP)
Stockholders' Equity Attributable to Parent, YoY Quarterly Change (%)

TC BioPharm (Holdings) plc Quarterly Stockholders' Equity Attributable to Parent (GBP)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 3.01M +324K +12.1% 31 Dec 2024 20-F 09 May 2025
Q2 2024 2M -364K -15.4% 30 Jun 2024 6-K 25 Nov 2024
Q1 2024 1.08M -36.1K -3.24% 31 Mar 2024 10-Q 15 May 2024
Q4 2023 2.69M +2.35M +711% 31 Dec 2023 20-F 09 May 2025
Q2 2023 2.37M 30 Jun 2023 6-K 25 Nov 2024
Q1 2023 1.12M 31 Mar 2023 10-Q 15 May 2024
Q4 2022 331K +16.9M 31 Dec 2022 20-F 09 May 2025
Q4 2021 -16.6M 31 Dec 2021 20-F 09 May 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.